Higher-likelihood alternative causes: In UK clinical guidance, GSM is a common and under-treated driver of dryness, dyspareunia and tissue fragility, and should be actively assessed, particularly in peri-/post-menopausal patients or those with iatrogenic hypo-oestrogenism
It is noteworthy that methodological limitations, such as the absence of nasal thermistor monitoring in the Donnell et al
The combination of GLP-1R agonists with each other has not been studied previously, suggesting that due to their similar mode of action, there would not be an enhancement in therapy from this combination
However, certain populations should exercise caution or avoid the product: Immunocompromised individuals: Any live probiotic carries theoretical risk in severely immunocompromised patients
Table 4 GRADE profile of L-carnitine for glycemic indices
Some patients prefer this format because they are already comfortable with weekly injections or want the familiarity of the traditional delivery method at a lower dose